HK1114565A1 - Pharmaceutical composition comprising 2, 3-dihydro-6-nitroimidazo [2, 1-b] oxazole derivatives - Google Patents
Pharmaceutical composition comprising 2, 3-dihydro-6-nitroimidazo [2, 1-b] oxazole derivativesInfo
- Publication number
- HK1114565A1 HK1114565A1 HK08110119.7A HK08110119A HK1114565A1 HK 1114565 A1 HK1114565 A1 HK 1114565A1 HK 08110119 A HK08110119 A HK 08110119A HK 1114565 A1 HK1114565 A1 HK 1114565A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- nitroimidazo
- dihydro
- pharmaceutical composition
- oxazole derivatives
- oxazole
- Prior art date
Links
- QISRGAUYEHQMJV-UHFFFAOYSA-N 6-nitro-2,3-dihydroimidazo[2,1-b][1,3]oxazole Chemical class C1COC2=NC([N+](=O)[O-])=CN21 QISRGAUYEHQMJV-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005218563 | 2005-07-28 | ||
| PCT/JP2006/314708 WO2007013477A1 (en) | 2005-07-28 | 2006-07-19 | Pharmaceutical composition comprising 2 , 3-dihydro-6-nitroimidazo [2 , 1-b] oxazole derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1114565A1 true HK1114565A1 (en) | 2008-11-07 |
Family
ID=37038507
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK08110119.7A HK1114565A1 (en) | 2005-07-28 | 2008-09-11 | Pharmaceutical composition comprising 2, 3-dihydro-6-nitroimidazo [2, 1-b] oxazole derivatives |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US7943623B2 (zh) |
| EP (1) | EP1906926B1 (zh) |
| JP (1) | JP4808246B2 (zh) |
| KR (1) | KR101294921B1 (zh) |
| CN (1) | CN101222913B (zh) |
| AR (1) | AR055357A1 (zh) |
| AT (1) | ATE489943T1 (zh) |
| AU (1) | AU2006273355B2 (zh) |
| CA (1) | CA2610749C (zh) |
| CY (1) | CY1111653T1 (zh) |
| DE (1) | DE602006018617D1 (zh) |
| DK (1) | DK1906926T3 (zh) |
| ES (1) | ES2355524T3 (zh) |
| HK (1) | HK1114565A1 (zh) |
| MX (1) | MX2008001210A (zh) |
| MY (1) | MY144554A (zh) |
| PL (1) | PL1906926T3 (zh) |
| PT (1) | PT1906926E (zh) |
| RU (1) | RU2413504C3 (zh) |
| SI (1) | SI1906926T1 (zh) |
| TW (1) | TWI382857B (zh) |
| UA (1) | UA95251C2 (zh) |
| WO (1) | WO2007013477A1 (zh) |
| ZA (1) | ZA200710404B (zh) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004285811B2 (en) * | 2003-10-31 | 2008-06-12 | Otsuka Pharmaceutical Co., Ltd. | 2,3-dihydro-6-nitroimidazo (2,1-B) oxazole compounds for the treatment of tuberculosis |
| TW201200523A (en) * | 2010-01-29 | 2012-01-01 | Otsuka Pharma Co Ltd | Synthetic intermediate of oxazole compound and method for producing the same |
| EP3052503B1 (en) | 2013-10-04 | 2018-10-24 | Council of Scientific & Industrial Research | 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles and a process for the preparation thereof |
| SG11202011908YA (en) | 2018-06-11 | 2020-12-30 | Otsuka Pharma Co Ltd | Delamanid-containing composition |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT901786E (pt) * | 1997-08-11 | 2007-08-07 | Pfizer Prod Inc | Disperções farmacêuticas sólidas com biodisponibilidade melhorada |
| JP2005523262A (ja) * | 2002-02-01 | 2005-08-04 | ファイザー・プロダクツ・インク | 薬物及び親油性ミクロ相形成物質の非晶質分散物の医薬組成物 |
| TWI347946B (en) * | 2002-10-11 | 2011-09-01 | Otsuka Pharma Co Ltd | 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound |
| AU2003301282B2 (en) * | 2002-10-15 | 2009-04-30 | Otsuka Pharmaceutical Co., Ltd. | 1-substituted 4-nitroimidazole compound and process for producing the same |
| JP4258630B2 (ja) * | 2002-10-15 | 2009-04-30 | 大塚製薬株式会社 | １位置換−４−ニトロイミダゾール化合物及びその製造法 |
| AU2004285811B2 (en) * | 2003-10-31 | 2008-06-12 | Otsuka Pharmaceutical Co., Ltd. | 2,3-dihydro-6-nitroimidazo (2,1-B) oxazole compounds for the treatment of tuberculosis |
-
2006
- 2006-07-19 PT PT06781620T patent/PT1906926E/pt unknown
- 2006-07-19 DE DE602006018617T patent/DE602006018617D1/de active Active
- 2006-07-19 EP EP06781620A patent/EP1906926B1/en active Active
- 2006-07-19 US US11/996,699 patent/US7943623B2/en active Active
- 2006-07-19 PL PL06781620T patent/PL1906926T3/pl unknown
- 2006-07-19 UA UAA200802496A patent/UA95251C2/ru unknown
- 2006-07-19 WO PCT/JP2006/314708 patent/WO2007013477A1/en active Application Filing
- 2006-07-19 MX MX2008001210A patent/MX2008001210A/es active IP Right Grant
- 2006-07-19 RU RU2008107595A patent/RU2413504C3/ru active Protection Beyond IP Right Term
- 2006-07-19 AT AT06781620T patent/ATE489943T1/de active
- 2006-07-19 SI SI200630877T patent/SI1906926T1/sl unknown
- 2006-07-19 DK DK06781620.7T patent/DK1906926T3/da active
- 2006-07-19 CA CA2610749A patent/CA2610749C/en active Active
- 2006-07-19 ES ES06781620T patent/ES2355524T3/es active Active
- 2006-07-19 AU AU2006273355A patent/AU2006273355B2/en active Active
- 2006-07-19 JP JP2008504290A patent/JP4808246B2/ja active Active
- 2006-07-19 KR KR1020087004656A patent/KR101294921B1/ko active Protection Beyond IP Right Term
- 2006-07-19 CN CN2006800258661A patent/CN101222913B/zh active Active
- 2006-07-20 TW TW095126526A patent/TWI382857B/zh active
- 2006-07-26 MY MYPI20063579A patent/MY144554A/en unknown
- 2006-07-28 AR ARP060103282A patent/AR055357A1/es not_active Application Discontinuation
-
2007
- 2007-11-30 ZA ZA200710404A patent/ZA200710404B/xx unknown
-
2008
- 2008-09-11 HK HK08110119.7A patent/HK1114565A1/xx unknown
-
2011
- 2011-02-14 CY CY20111100174T patent/CY1111653T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS1400051I1 (hu) | Lurazidont tartalmazó gyógyászati készítmény | |
| ZA200803758B (en) | Oxazole compound and pharmaceutical composition | |
| IL191907A0 (en) | Azepinoindole derivatives as pharmaceutical agents | |
| IL225207A (en) | A derivative of multi-ring carbamoylpyridone, its pharmaceutical composition, its use and its preparation | |
| IL192298A (en) | Heterocyclic Compounds, Their Acceptable Salts, Pharmaceuticals Containing and Using Them | |
| IL223477A (en) | Pharmaceutical preparation containing modified enzyme uricase | |
| IL195488A (en) | Compounds, pharmaceuticals containing them and their uses | |
| IL186336A0 (en) | Pharmaceutical composition | |
| IL187534A0 (en) | Thiazole derivatives, use thereof and pharmaceutical compositions containing them | |
| IL187392A0 (en) | Thiazole derivatives, their preparation and use | |
| IL192826A0 (en) | Thiazole derivatives, their preparation and pharmaceutical compositions containing them | |
| TWI315305B (en) | Piperidin-4-yl-amide derivatives,pharmaceutical compositions comprising the same,process for preparing the same and the use thereof | |
| HK1116482A1 (en) | Oxazolidinone derivatives and use thereof as antibiotics | |
| EP1937255A4 (en) | PHARMACEUTICAL COMPOSITION | |
| EP1862184A4 (en) | PHARMACEUTICAL COMPOSITION | |
| HK1114565A1 (en) | Pharmaceutical composition comprising 2, 3-dihydro-6-nitroimidazo [2, 1-b] oxazole derivatives | |
| IL187419A0 (en) | Heteroarylethenyl derivatives, their manufacture and use as pharmaceutical agents | |
| IL191560A0 (en) | 3,4-dihydrobenzoxazine derivatives and pharmaceutical compositions containing the same | |
| DE602006003956D1 (en) | Novel polysubstituted 1,1-pyridinylaminocyclopropanamine derivatives, processes for their preparation and pharmaceutical composition containing them | |
| GB0518166D0 (en) | Pharmaceutical composition | |
| GB0511801D0 (en) | Pharmaceutical composition | |
| ZA200803112B (en) | Pharmaceutical composition | |
| ZA200800392B (en) | Pharmaceutical composition | |
| GB0504276D0 (en) | Pharmaceutical composition | |
| GB0500138D0 (en) | Pharmaceutical composition |